297 related articles for article (PubMed ID: 28059042)
1. Alkaloids as Cyclooxygenase Inhibitors in Anticancer Drug Discovery.
Hashmi MA; Khan A; Farooq U; Khan S
Curr Protein Pept Sci; 2018; 19(3):292-301. PubMed ID: 28059042
[TBL] [Abstract][Full Text] [Related]
2. Natural products and their derivatives as cyclooxygenase-2 inhibitors.
Chandel P; Rawal RK; Kaur R
Future Med Chem; 2018 Oct; 10(20):2471-2492. PubMed ID: 30325206
[TBL] [Abstract][Full Text] [Related]
3. Influencing COX-2 Activity by COX Related Pathways in Inflammation and Cancer.
Yu T; Lao X; Zheng H
Mini Rev Med Chem; 2016; 16(15):1230-1243. PubMed ID: 27145850
[TBL] [Abstract][Full Text] [Related]
4. Discovery of novel hybrids of diaryl-1,2,4-triazoles and caffeic acid as dual inhibitors of cyclooxygenase-2 and 5-lipoxygenase for cancer therapy.
Cai H; Huang X; Xu S; Shen H; Zhang P; Huang Y; Jiang J; Sun Y; Jiang B; Wu X; Yao H; Xu J
Eur J Med Chem; 2016 Jan; 108():89-103. PubMed ID: 26638042
[TBL] [Abstract][Full Text] [Related]
5. Novel Thiourea Derivatives Bearing Sulfonamide Moiety as Anticancer Agents Through COX-2 Inhibition.
Ghorab MM; El-Gaby MSA; Alsaid MS; Elshaier YAMM; Soliman AM; El-Senduny FF; Badria FA; Sherif AYA
Anticancer Agents Med Chem; 2017; 17(10):1411-1425. PubMed ID: 28356021
[TBL] [Abstract][Full Text] [Related]
6. Selective COX-2 inhibitors as anticancer agents: a patent review (2014-2018).
Mahboubi Rabbani SMI; Zarghi A
Expert Opin Ther Pat; 2019 Jun; 29(6):407-427. PubMed ID: 31132889
[TBL] [Abstract][Full Text] [Related]
7. Coumarins scaffolds as COX inhibitors.
Revankar HM; Bukhari SN; Kumar GB; Qin HL
Bioorg Chem; 2017 Apr; 71():146-159. PubMed ID: 28222891
[TBL] [Abstract][Full Text] [Related]
8. Natural-Derived COX-2 Inhibitors as Anticancer Drugs: A Review of their Structural Diversity and Mechanism of Action.
Mahboubi-Rabbani M; Abbasi M; Zarghi A
Anticancer Agents Med Chem; 2023; 23(1):15-36. PubMed ID: 35638275
[TBL] [Abstract][Full Text] [Related]
9. Alkaloids and Colon Cancer: Molecular Mechanisms and Therapeutic Implications for Cell Cycle Arrest.
Khan H; Alam W; Alsharif KF; Aschner M; Pervez S; Saso L
Molecules; 2022 Jan; 27(3):. PubMed ID: 35164185
[TBL] [Abstract][Full Text] [Related]
10. Cyclooxygenase-2 inhibitors in lung cancer treatment: Bench to bed.
Liu R; Xu KP; Tan GS
Eur J Pharmacol; 2015 Dec; 769():127-33. PubMed ID: 26548623
[TBL] [Abstract][Full Text] [Related]
11. Application of a Validated QSTR Model for Repurposing COX-2 Inhibitor Coumarin Derivatives as Potential Antitumor Agents.
Tugcu G; Sipahi H; Aydin A
Curr Top Med Chem; 2019; 19(13):1121-1128. PubMed ID: 31210111
[TBL] [Abstract][Full Text] [Related]
12. Anticancer and Reversing Multidrug Resistance Activities of Natural Isoquinoline Alkaloids and their Structure-activity Relationship.
Qing ZX; Huang JL; Yang XY; Liu JH; Cao HL; Xiang F; Cheng P; Zeng JG
Curr Med Chem; 2018; 25(38):5088-5114. PubMed ID: 28933285
[TBL] [Abstract][Full Text] [Related]
13. The discovery and development of cyclooxygenase-2 inhibitors as potential anticancer therapies.
Vosooghi M; Amini M
Expert Opin Drug Discov; 2014 Mar; 9(3):255-67. PubMed ID: 24483845
[TBL] [Abstract][Full Text] [Related]
14. Novel N-substituted indole Schiff bases as dual inhibitors of cyclooxygenase-2 and 5-lipoxygenase enzymes: Synthesis, biological activities in vitro and docking study.
Lamie PF; Ali WAM; Bazgier V; Rárová L
Eur J Med Chem; 2016 Nov; 123():803-813. PubMed ID: 27541263
[TBL] [Abstract][Full Text] [Related]
15. Hit identification and biological evaluation of anticancer pyrazolopyrimidines endowed with anti-inflammatory activity.
Alcaro S; Artese A; Botta M; Zizzari AT; Orallo F; Ortuso F; Schenone S; Brullo C; Yáñez M
ChemMedChem; 2010 Aug; 5(8):1242-6. PubMed ID: 20564576
[No Abstract] [Full Text] [Related]
16. Development of Natural Bioactive Alkaloids: Anticancer Perspective.
Patel A; Vanecha R; Patel J; Patel D; Shah U; Bambharoliya T
Mini Rev Med Chem; 2022; 22(2):200-212. PubMed ID: 34254913
[TBL] [Abstract][Full Text] [Related]
17. Naturally occurring plant isoquinoline N-oxide alkaloids: their pharmacological and SAR activities.
Dembitsky VM; Gloriozova TA; Poroikov VV
Phytomedicine; 2015 Jan; 22(1):183-202. PubMed ID: 25636889
[TBL] [Abstract][Full Text] [Related]
18. Dual-target inhibitors based on COX-2: a review from medicinal chemistry perspectives.
Zhang F; Zhu G; Li Y; Qi Y; Wang Z; Li W
Future Med Chem; 2023 Dec; 15(23):2209-2233. PubMed ID: 38095081
[TBL] [Abstract][Full Text] [Related]
19. Natural Product Inhibitors of Cyclooxygenase (COX) Enzyme: A Review on Current Status and Future Perspectives.
Ambati GG; Jachak SM
Curr Med Chem; 2021; 28(10):1877-1905. PubMed ID: 32484764
[TBL] [Abstract][Full Text] [Related]
20. Discovery of a potent cyclooxygenase-2 inhibitor, S4, through docking-based pharmacophore screening, in vivo and in vitro estimations.
Tseng TS; Chuang SM; Hsiao NW; Chen YW; Lee YC; Lin CC; Huang C; Tsai KC
Mol Biosyst; 2016 Jul; 12(8):2541-51. PubMed ID: 27265567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
